Thrombosis news, opinions and education

heartwire News

  • Alert Penumbra 3D Stroke Revascularization Device Recalled The class I recall, posted today by the FDA, was issued because of the risk that wire material may break or separate during use.
  • Bleeding Common Years After TAVR, and Deadly Registry findings highlight an underappreciated risk after transcatheter aortic valve replacement--late nonaccess site bleeding--and the pressing need to fine-tune postprocedure anticoagulant and antiplatelet therapy.
  • ISTH Shorter Compression Stocking Time May Be OK for Some With DVT Serial evaluation using signs and symptoms scores can indicate which patients with deep vein thrombosis may be able to use compression stockings for less than 2 years, a randomized study suggests.
  • ISTH Novel Agent Reduces Antithrombin Levels to Treat Hemophilia Fitusiran, an RNA interference agent, safely reduces antithrombin levels to allow clot formation to treat hemophilia A or B in patients with or without inhibitors, a study shows.

Perspective